About
Kevin Caldwell is the CEO, Co-Founder, and President of Ossium Health, a clinical-stage bioengineering company developing stem-cell-based therapies and bone marrow banking infrastructure. Before founding Ossium in 2016, he worked at McKinsey advising biotechnology and healthcare clients and earlier was a Senior Investment Associate at Bridgewater Associates. His public profile is strongest as an operating biotech founder in the longevity and regenerative-medicine ecosystem rather than as a capital allocator.
Areas of interest
longevitybiotechbioengineeringstem cell therapiesregenerative medicinetransplant medicinecell therapy